Current role
Biotechnology · Healthcare
CEO, Board Member
2026-01-01–present
Matthew Angel
Board Member
Tempest Therapeutics, Inc. (TPST)Equibles does not estimate personal net worth.
Get an email with a short summary when Tempest Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get TPST alertsAbout Matthew Angel
Matthew Angel is recorded as Board Member at Tempest Therapeutics, Inc. (TPST) since January 1, 2026 and CEO at Tempest Therapeutics, Inc. (TPST). The newest filing on record that lists Matthew Angel as CEO and Board Member at Tempest Therapeutics, Inc. (TPST) is dated October 26, 2026. Tempest Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Tempest Therapeutics, Inc. includes Louis J. Arcudi III (CEO and Board Member), Matt Angel (CEO and Board Member), Matt Angel, Ph.D. (CEO and Board Member) and 7 others.
Affiliation history
-
Current
2026-01-01–present
Last confirmed October 26, 2026
-
Current
Start not stated–present
Last confirmed October 26, 2026
Company network
Leadership on record at Tempest Therapeutics, Inc.
- Louis J. Arcudi III CEO, Board Member
- Matt Angel CEO, Board Member
- Matt Angel, Ph.D. CEO, Board Member
- Stephen R. Brady CEO
- Julia C. Owens Chairman
- Mike Raab Chairman, Board Member
- Stephen Brady Chairman
- Constance Ames CFO
- Jennifer Minai-Azary CFO
- Justin Trojanowski CFO, Chief Accounting Officer
Recent activity
No call appearances or filed executive changes recorded yet.